このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Cutera 過去の業績

過去基準チェック /06

Cuteraの収益は年間平均-45%の割合で減少していますが、 Medical Equipment業界の収益は年間増加しています。収益は年間8.7% 8.7%割合で増加しています。

主要情報

-45.0%

収益成長率

-36.8%

EPS成長率

Medical Equipment 業界の成長	8.9%
収益成長率	8.7%
株主資本利益率	n/a
ネット・マージン	-80.1%
前回の決算情報	31 Mar 2024

Recent updates

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 28% Dive

Jun 22

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 35% Dive

Mar 14

Analysts Are More Bearish On Cutera, Inc. (NASDAQ:CUTR) Than They Used To Be

Aug 11

An Intrinsic Calculation For Cutera, Inc. (NASDAQ:CUTR) Suggests It's 48% Undervalued

Apr 19

Cutera, Inc. (NASDAQ:CUTR) Shares Could Be 49% Below Their Intrinsic Value Estimate

Sep 01

Cutera: The 'AviClear' Sign To Get Bullish

Jun 22

Cutera (NASDAQ:CUTR) Is Carrying A Fair Bit Of Debt

May 27

Returns On Capital Signal Tricky Times Ahead For Cutera (NASDAQ:CUTR)

Apr 22

Cutera: Gains Aren't Surprising After Acne Laser Therapy Cleared

Mar 31

What Does Cutera, Inc.'s (NASDAQ:CUTR) Share Price Indicate?

Feb 23

We Think Cutera (NASDAQ:CUTR) Can Stay On Top Of Its Debt

Jan 08

Revisiting Cutera

Dec 18

収支内訳

Cutera の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

NasdaqGS:CUTR 収益、費用、利益 ( )USD Millions
日付	収益	収益	G+A経費	研究開発費
31 Mar 24	197	-158	159	20
31 Dec 23	212	-163	164	21
30 Sep 23	230	-113	175	22
30 Jun 23	247	-81	162	24
31 Mar 23	249	-95	156	25
31 Dec 22	252	-82	153	25
30 Sep 22	251	-78	147	27
30 Jun 22	245	-68	137	26
31 Mar 22	240	-13	126	24
31 Dec 21	231	2	110	22
30 Sep 21	216	8	98	19
30 Jun 21	197	7	91	16
31 Mar 21	165	-12	83	15
31 Dec 20	148	-24	84	14
30 Sep 20	150	-28	87	15
30 Jun 20	157	-29	93	15
31 Mar 20	178	-17	96	15
31 Dec 19	182	-12	95	15
30 Sep 19	175	-37	90	14
30 Jun 19	170	-35	84	14
31 Mar 19	165	-37	83	15
31 Dec 18	163	-31	79	14
30 Sep 18	165	18	78	14
30 Jun 18	162	25	75	15
31 Mar 18	156	29	71	13
31 Dec 17	151	30	66	13
30 Sep 17	142	11	61	12
30 Jun 17	134	7	58	12
31 Mar 17	125	4	57	11
31 Dec 16	118	3	55	11
30 Sep 16	110	0	53	11
30 Jun 16	103	-2	51	11
31 Mar 16	98	-3	49	11
31 Dec 15	95	-4	48	11
30 Sep 15	90	-8	48	11
30 Jun 15	86	-10	47	10
31 Mar 15	81	-11	45	10
31 Dec 14	78	-11	43	11
30 Sep 14	75	-9	42	10
30 Jun 14	73	-8	40	10
31 Mar 14	75	-6	39	10
31 Dec 13	75	-5	38	9
30 Sep 13	75	-3	37	9
30 Jun 13	77	-3	37	9

質の高い収益: CUTRは現在利益が出ていません。

利益率の向上: CUTRは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: CUTRは利益が出ておらず、過去 5 年間で損失は年間45%の割合で増加しています。

成長の加速: CUTRの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: CUTRは利益が出ていないため、過去 1 年間の収益成長をMedical Equipment業界 ( 2.4% ) と比較することは困難です。

株主資本利益率

高いROE: CUTRの負債は資産を上回っているため、自己資本利益率を計算することは困難です。

Cutera 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

Cutera, Inc. to Report Q1, 2024 Results on May 09, 2024

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Cutera, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Cutera, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Cutera, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Recent updates

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 28% Dive

Price target decreased by 17% to US$6.33

High number of new and inexperienced directors

Cutera, Inc., Annual General Meeting, Jul 15, 2024

Cutera, Inc. Reiterates Earnings Guidance for 2024

Cutera, Inc. to Report Q1, 2024 Results on May 09, 2024

Cutera, Inc. Announces North America Launch of xeo+

Cutera, Inc. Provides Revenue Guidance for the Full Year 2024

Cutera, Inc. announced delayed annual 10-K filing

Revenues Working Against Cutera, Inc.'s (NASDAQ:CUTR) Share Price Following 35% Dive

Consensus EPS estimates fall by 33%

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Cutera, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Price target decreased by 59% to US$7.67

High number of new and inexperienced directors

Cutera, Inc. Revises Revenue Guidance for the Full Year 2023

Cutera, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-Q

Cutera, Inc. announced delayed 10-Q filing

Cutera, Inc. Announces Resignation of Juliane Park from the Board of Directors, Effective as of December 1, 2023

Cutera, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Janet Widmann Resigns from the Board of Directors of Cutera, Inc. Effective November 1, 2023

New minor risk - Market cap size

Cutera, Inc. Appoints Brent Hauser as President, International

Cutera, Inc. Announces the Launch of New Skin Resurfacing and Revitalization Platform Secret DUO

President recently bought US$297k worth of stock

Cutera, Inc. Appoints Jeffrey Jones as Chief Operating Officer, Effective August 28, 2023

Consensus revenue estimates fall by 14%

Analysts Are More Bearish On Cutera, Inc. (NASDAQ:CUTR) Than They Used To Be

New major risk - Share price stability

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 8.9% to US$23.00

Cutera, Inc. Provides Revenue Guidance for the Full Year 2023

Cutera, Inc. Appoints Talyor C. Harris as President, Effective August 7, 2023

Cutera, Inc. Announces CEO Changes, Effective August 7, 2023

Cutera, Inc. to Report Q2, 2023 Results on Aug 08, 2023

the Gross Law Firm Notifies Shareholders of Cutera, Inc. of A Class Action Lawsuit and A Lead Plaintiff Deadline of July 24, 2023

Cutera, Inc. Announces A New U.S. Food and Drug Administration Clearance of AviClear as A Long-Term Treatment for Mild to Severe Inflammatory Acne Vulgaris

Cutera, Inc. Announces Resignation of J. Daniel Plants as Director

Independent Director notifies of intention to sell stock

Cutera, Inc. Announces Resignation of Joseph E. Whitters from the Board of Directors

Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against Cutera, Inc

Less than half of directors are independent

Cutera, Inc. Announces Board Changes

Cutera, Inc. Appoints Stuart Drummond as Interim Chief Financial Officer

Voce Capital and David Mowry Terminate Proxy Solicitation

Cutera, Inc. Announces Chief Financial Officer Changes

First quarter 2023 earnings: EPS and revenues miss analyst expectations

An Intrinsic Calculation For Cutera, Inc. (NASDAQ:CUTR) Suggests It's 48% Undervalued

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 57%

Now 21% undervalued after recent price drop

Full year 2022 earnings: EPS misses analyst expectations

Does Cutera (NASDAQ:CUTR) Have A Healthy Balance Sheet?

Price target decreased to US$61.20

Cutera, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Cutera, Inc. Announces AviClear™ Now Broadly Available to US Physicians and Practitioners Upon National Launch

Third quarter 2022 earnings released: US$0.62 loss per share (vs US$0.077 loss in 3Q 2021)

Cutera, Inc. Reiterates Revenue Guidance for the Full Year of 2022

Cutera, Inc. Announces Committee Appointments

Cutera, Inc. to Report Q3, 2022 Results on Nov 03, 2022

Would Cutera (NASDAQ:CUTR) Be Better Off With Less Debt?

Cutera, Inc. Announces Resignation of Katherine S. Zanotti from the Board

Cutera: Shares Very Attractively Priced, Top-Line Hedged From CMS

Cutera, Inc. (NASDAQ:CUTR) Shares Could Be 49% Below Their Intrinsic Value Estimate

Cutera, Inc. Reiterates Revenue Guidance for the Full Year of 2022

Second quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Cutera, Inc. to Report Q2, 2022 Results on Aug 04, 2022

Cutera, Inc. Announces AviClear Secured Clearance from Health Canada

Cutera: The 'AviClear' Sign To Get Bullish

過去基準チェック /06